SQUAMOUS CELL LUNG CANCER
Clinical trials for SQUAMOUS CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Custom-Made vaccine targets tough cancers in early trial
Disease control TerminatedThis early-phase trial tests a personalized vaccine (PANDA-VAC) made from a patient's own tumor mutations, given alongside the immunotherapy drug pembrolizumab. The study includes up to 6 adults with advanced squamous lung or head/neck cancer that cannot be cured. The main goal i…
Matched conditions: SQUAMOUS CELL LUNG CANCER
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated May 26, 2026 12:09 UTC
-
New radiation combo aims to shrink inoperable lung tumors
Disease control OngoingThis study tested a new way of giving radiation therapy (called hypofractionated radiotherapy with a stereotactic boost) along with standard chemotherapy for people with stage II or III non-small cell lung cancer that cannot be removed by surgery. The goal was to find the highest…
Matched conditions: SQUAMOUS CELL LUNG CANCER
Phase: NA • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated May 26, 2026 12:03 UTC
-
New hope for hard-to-treat cancers: experimental drug enters human testing
Disease control OngoingThis early-stage study tests a new drug called TT125-802 in about 50 adults with advanced solid tumors that have stopped responding to standard treatments. The main goals are to check the drug's safety and find the best dose. Researchers will also watch for any tumor shrinkage an…
Matched conditions: SQUAMOUS CELL LUNG CANCER
Phase: PHASE1 • Sponsor: TOLREMO therapeutics AG • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
Gene-Edited cell therapy for lung cancer trial pulled before start
Disease control TerminatedThis trial aimed to test a new treatment for people with metastatic non-small cell lung cancer. It used a patient's own immune cells (TILs) that were edited with CRISPR to remove a gene called CISH, potentially making them better at fighting cancer. The study was withdrawn before…
Matched conditions: SQUAMOUS CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Intima Bioscience, Inc. • Aim: Disease control
Last updated May 20, 2026 11:55 UTC